Our Privacy Statement & Cookie Policy

By continuing to browse our site you agree to our use of cookies, revised Privacy Policy and Terms of Use. You can change your cookie settings through your browser.

I agree

Epredia: 'Huge opportunity' in Chinese market

 , Updated 12:47, 01-Mar-2024

China's healthcare market is "very unique" and is expected to grow roughly 7 percent in 2024, Steven Lynum, president of the U.S.-based precision diagnostics company Epredia, told CGTN. He added that providing more products that are manufactured in China and can support China is a "huge opportunity." 

Search Trends